Enabling quicker research, development, and production for upstream bioprocessing through scale out Like the cells they culture, bioreactors come in various shapes, sizes, and specialties. While they ...

An equine cell therapy manufacturing process that uses vertical bioreactors could help the wider industry reduce production and ultimately product costs, according to the authors of a new study. The ...

One of the most important advances in the field of cell biology came in the early 20th century, with the discovery that plant and animal cells could survive - and even replicate - outside the living ...

In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.

Although bioreactor scale-up often involves matching key engineering parameters, a biology-first approach should dictate the process.

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, producing cell aggregates in bioreactors is highly complex and cost-intensive.

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...